Fingerprint
Dive into the research topics of 'A randomized assessment of adding the kinase inhibitor lestaurtinib to first-line chemotherapy for FLT3-mutated AML'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Steven Knapper, Nigel Russell, Amanda Gilkes, Robert K. Hills, Rosemary E. Gale, James D. Cavenagh, Gail Jones, Lars Kjeldsen, Michael R. Grunwald, Ian Thomas, Heiko Konig, Mark J. Levis, Alan K. Burnett
Research output: Contribution to journal › Article › peer-review